Home › Funds › Lynx1 Capital Management LP › DTIL
Lynx1 Capital Management LP position in DTIL
PRECISION BIOSCIENCES INC · Health Care
Lynx1 Capital Management LP reported holding 950,466 shares of DTIL (PRECISION BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$7.5M, representing 0.86% of its reported portfolio and ranking #8 among its reported holdings. Lynx1 Capital Management LP has disclosed DTIL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lynx1 Capital Management LP's DTIL position evolved
Lynx1 Capital Management LP first disclosed a stake in DTIL in Q4 2024 at 766,051 shares (US$2.9M). The position peaked in Q2 2026 at 950,466 shares, worth US$7.5M. Across 7 filings, Lynx1 Capital Management LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 950,466 shares valued at US$7.5M — a reduction of -34,647 shares quarter over quarter.. Notable position changes include a 35% increase in Q2 2025 (shares rose 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 766.05K | $2.92M | New |
| Q1 2025 | 766.05K | $3.65M | Hold |
| Q2 2025 | 1.04M | $4.35M | Add |
| Q3 2025 | 1.04M | $5.76M | Add |
| Q4 2025 | 993.91K | $4.13M | Reduce |
| Q1 2026 | 985.11K | $5.42M | Reduce |
| Q2 2026 | 950.47K | $7.47M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DTIL and 13F data
DTIL (PRECISION BIOSCIENCES INC) is a Health Care company. 55 other funds we track also report a position in DTIL — the largest reported positions include Bleichroeder LP (US$15.9M), Octagon Capital Advisors LP (US$10.6M), Empery Asset Management, LP (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DTIL
- Bleichroeder LP 2.02M sh · $15.86M · Q2 2026
- Octagon Capital Advisors LP 1.35M sh · $10.61M · Q2 2026
- Empery Asset Management, LP 776.09K sh · $6.10M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $314.40K · Q2 2026
More on Lynx1 Capital Management LP
FAQ
How long has Lynx1 Capital Management LP held DTIL?
Lynx1 Capital Management LP has disclosed DTIL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Lynx1 Capital Management LP's current position in DTIL?
As of Q2 2026, Lynx1 Capital Management LP holds 950.47K shares of DTIL (PRECISION BIOSCIENCES INC), valued at $7.47M, representing 0.86% of its reported portfolio and ranking #8.
Has Lynx1 Capital Management LP been buying or selling DTIL?
In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP reduced its position in DTIL. The position peaked in Q2 2026 at 950.47K shares.
Which other funds hold DTIL?
Other major institutional holders of DTIL include Bleichroeder LP, Octagon Capital Advisors LP, Empery Asset Management, LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.